Cited by 52Eating Disorders and BehaviorsPharmacology and Obesity TreatmentNutrition, Health and Food Behavior

Current and emerging drug treatments for binge eating disorder

Open access
Reas, Deborah L, Grilo, Carlos M·2014·Expert Opinion on Emerging Drugs

Abstract

INTRODUCTION: This study evaluated controlled treatment studies of pharmacotherapy for binge eating disorder (BED). AREAS COVERED: The primary focus of the review was on Phase II and III controlled trials testing medications for BED. A total of 46 studies were considered and 26 were reviewed in detail. BED outcomes included binge eating remission, binge eating frequency, associated eating disorder psychopathology, associated depression and weight loss. EXPERT OPINION: Data from controlled trials suggest that certain medications are superior to placebo for stopping binge eating and for producing faster reductions in binge eating, and - to varying degrees - for reducing associated eating disorder psychopathology, depression and weight loss over the short term. Almost no data exist regarding longer-term effects of medication for BED. Except for topiramate, which reduces both binge eating and weight, weight loss is minimal with medications tested for BED. Psychological interventions and the combination of medication with psychological interventions produce binge eating outcomes that are superior to medication-only approaches. Combining medications with psychological interventions does not significantly enhance binge eating outcomes, although the addition of certain medications enhances weight losses achieved with cognitive-behavioral therapy and behavioral weight loss, albeit modestly.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1517/14728214.2014.879291

Cites

63 of 63 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Reas, D. L., & Grilo, C. M.
Affiliations
  • Oslo University Hospital (NO)
  • Yale University (US)
Venue
Expert Opinion on Emerging Drugs
Published
2014-01-25
Volume
19
Issue
1
Pages
99-142
ISSN
  • 1472-8214 (ISSN-L)
  • 1744-7623
OpenAlex
W2066879366
Cited by
52
References
63
Citations by year
2024: 2 · 2023: 3 · 2022: 3 · 2021: 1 · 2020: 2 · 2019: 2 · 2018: 8 · 2017: 5 · 2016: 7 · 2015: 15 · 2014: 4
FWCI
1.56
Type
journal article
Language
en
Open access
Locations
  • Expert Opinion on Emerging Drugs (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
National Institute of Diabetes and Digestive and Kidney Diseases (R01DK49587, R01DK073542, R01DK049587, K24DK070052)
Topics
  • Social Sciences › Psychology › Clinical Psychology › Eating Disorders and Behaviors
  • Health Sciences › Medicine › Pharmacology › Pharmacology and Obesity Treatment
  • Health Sciences › Nursing › Nutrition and Dietetics › Nutrition, Health and Food Behavior
Keywords
binge eating disorder, pharmacotherapy, topiramate, antidepressants, weight loss, depression, eating disorder psychopathology, cognitive behavioral therapy, behavioral weight loss, combination therapy
MeSH terms
Depression, Humans, Weight Loss, Clinical Trials, Phase II as Topic, Clinical Trials, Phase III as Topic, Binge-Eating Disorder

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review